Heterologous carcinosarcoma of Douglas' pouch with adenocarcinomas of the fallopian tube and the peritoneal cavity

Pathology

Volumn 40, Issue 6, 2008, Pages 641-645

  Kataoka, Tatsuki R ^a,b   Shinoda, Hiroko ^b,c   Yanagawa, Masahiro ^a,b   Kamiura, Shoji ^b   Nishizawa, Yasuko ^a,b   Hongyo, Tadashi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; CISPLATIN; IFOSFAMIDE; K RAS PROTEIN; PACLITAXEL; PROTEIN BAK; PROTEIN P53; STEM CELL FACTOR;

ABDOMINAL HYSTERECTOMY; AGED; ANAMNESIS; CARCINOSARCOMA; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LETTER; MUTATIONAL ANALYSIS; PERITONEAL CAVITY; PERITONEUM CANCER; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; RECTOUTERINE POUCH; SALPINGOOOPHORECTOMY; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE TUBE CARCINOMA;

EID: 50449104504     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802320721     Document Type: Article

References (12)

1. de-Brito PA, Silverberg SG, Orenstein JM. Carcinosarcoma (malignant mixed müllerian [mesodermal] tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases. Hum Pathol 1993; 24: 132-42.
2. Garamvoelgyi E, Guillou L, Gehard S, et al. Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature. Cancer 1994; 74: 854-63.
3. Shen D-H, Khoo U-S, Xue W-C, et al. Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study. Cancer 2001; 91: 1052-60.
4. Hongyo T, Hoshida Y, Nakatsuka S, et al. p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan. Oncol Rep 2005; 13: 265-71.
5. Wani KM, Huilgol NG, Hongyo T, et al. Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma. Br J Cancer 2003; 88: 1584-6.
6. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
7. Gorstein F, Anderson TL. Malignant mixed mesodermal tumors: carcinoma, sarcoma, or both? Hum Pathol 1991; 22: 207-9.
8. Ishiwata I, Ono I, Ishiwata C, et al. Heterotransplantation of mixed mesodermal tumor cells in nude mouse-Histology of metastatic foci. Gynecol Oncol 1987; 27: 189-96.
9. Wada H, Enomoto T, Fujita M, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 1997; 57: 5379-85.
10. Fujii H, Yoshida M, Gong ZX, et al. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 2000; 60: 114-20.
11. Streenan JJ, Hart WR. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 1995; 19: 666-74.
12. Mikami M, Kuwabara Y, Tanaka K, et al. Malignant mixed müllerian tumor of primary mesenteric origin. Int J Gynecol Cancer 2005; 15: 1249-53.